HPβCD’s Promise in Treating Ischemic Stroke
Ischemic stroke is a leading cause of mortality and long-term disability worldwide, with limited pharmacological interventions available. 2-hydroxypropyl-β-cyclodextrin (HPβCD), a
National Cyclodextrin Symposium (35CDS) in Japan
35th National Cyclodextrin Symposium (35CDS) organized by the Society of Cyclodextrins, Japan will be held in Kofu on Sept. 6-7,
HPαCD More Effective than HPβCD Against Breast Cancer
Wittkowski et al. recently published their results on re-evaluation of three genome-wide association studies using computational biostatistics approach. The genetic
Cyclodextrin. A Versatile Ingredient
IntechOpen leading publisher of open access books published a new book on cyclodextrins edited by P. Arora & N. Dhingra.
New books on cyclodextrins
Three new books on various aspects of cyclodextrin research and applications have been recently published. 1. Cyclodextrin Fundamentals, Reactivity and
First cannabidiol product approved by FDA as medication
Cannabis has been used for medicinal purposes for thousands of years. Its active compounds produce pharmacological effects throughout the body,
József Szejtli Award in 2018
Nicolas Blanchemain, assistant professor at the University of Lille, received the 2018. Jozsef Szejtli Award, which was handed over by
EuroCD2019
The 6th European Cyclodextrin Conference will be held in Santiago de Compostela on October 2–4, 2019. Seven plenary lectures will
HPBCD can cross the Brain-Blood Barrier
Matencio et al. reported in their recent paper that 92.8% of HPBCD administered intrathecally to a child suffering from Niemann
Phosphates of cyclodextrin polymers
The synthesis of β-CD polymer phosphate sodium salts was worked out to be used for coating of metal-organic framework (MOF)
Cyclodextrin Phosphates
In order to develop cyclodextrin derivatives having improved aqueous solubility, high solubilizing power, and low accumulation upon longer administration charged